The cuprotosis related DLD gene has been proven to be a potential therapeutic target for COVID-19 infected DLBCL patients [21], suggesting that CRGs play an important role in the mechanism of COVID-19 infected DLBCL patients. Here, DLD is linked to COVID-19.